May 5, 2020 / 11:23 AM / a month ago

BRIEF-Karyopharm Therapeutics Reports Q1 Loss Per Share Of $0.78

May 5 (Reuters) - Karyopharm Therapeutics Inc:

* KARYOPHARM REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS

* Q1 LOSS PER SHARE $0.78

* Q1 EARNINGS PER SHARE ESTIMATE $-0.69 — REFINITIV IBES DATA

* NET PRODUCT REVENUE FOR Q1 OF 2020 WAS $16.1 MILLION. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below